|
CRVS Corvus Pharmaceuticals Inc 1626971 |
| Balance Sheet |
|
Current Assets
|
42,921,000 |
|
Assets
|
58,815,000 |
|
Current Liabilities
|
46,406,000 |
|
Liabilities
|
46,406,000 |
|
Equity
|
12,409,000 |
|
Shares Out
|
62,551,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-16,959,000 |
|
Investing Cash Flow
|
-21,401,000 |
| Market Analysis |
Market Cap
|
347,785,057 |
|
Price
|
5.01 |
|
BVPS
|
0.20 |
|
PB
|
25.10 |
|
EPS
|
-0.45 |
|
PS
|
5.26 |
|
FCF
|
-38,360,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CRVS documents filed with the SEC.
CRVS Filings
Clear
